Annual Net Income
-$171.67 M
+$32.54 M+15.94%
31 December 2023
Summary:
Mersana Therapeutics annual net profit is currently -$171.67 million, with the most recent change of +$32.54 million (+15.94%) on 31 December 2023. During the last 3 years, it has fallen by -$83.63 million (-94.98%). MRSN annual net income is now -1153.07% below its all-time high of -$13.70 million, reached on 31 December 2016.MRSN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$11.50 M
+$12.77 M+52.61%
30 September 2024
Summary:
Mersana Therapeutics quarterly net profit is currently -$11.50 million, with the most recent change of +$12.77 million (+52.61%) on 30 September 2024. Over the past year, it has increased by +$30.16 million (+72.39%). MRSN quarterly net income is now -152.51% below its all-time high of $21.90 million, reached on 31 March 2019.MRSN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$74.62 M
+$30.16 M+28.78%
30 September 2024
Summary:
Mersana Therapeutics TTM net profit is currently -$74.62 million, with the most recent change of +$30.16 million (+28.78%) on 30 September 2024. Over the past year, it has increased by +$122.43 million (+62.13%). MRSN TTM net income is now -1293.19% below its all-time high of -$5.36 million, reached on 31 March 2016.MRSN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.9% | +72.4% | +62.1% |
| 3 y3 years | -95.0% | +74.7% | +50.2% |
| 5 y5 years | -167.2% | +31.5% | -117.0% |
MRSN Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -95.0% | +15.9% | at high | +80.8% | at high | +65.3% |
| 5 y | 5 years | -508.6% | +15.9% | at high | +80.8% | -164.5% | +65.3% |
| alltime | all time | -1153.1% | +15.9% | -152.5% | +80.8% | -1293.2% | +65.3% |
Mersana Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.50 M(-52.6%) | -$74.62 M(-28.8%) |
| June 2024 | - | -$24.27 M(+25.7%) | -$104.77 M(-22.3%) |
| Mar 2024 | - | -$19.31 M(-1.2%) | -$134.81 M(-21.5%) |
| Dec 2023 | -$171.67 M(-15.9%) | -$19.54 M(-53.1%) | -$171.67 M(-12.9%) |
| Sept 2023 | - | -$41.66 M(-23.3%) | -$197.05 M(-8.4%) |
| June 2023 | - | -$54.31 M(-3.3%) | -$215.21 M(+1.0%) |
| Mar 2023 | - | -$56.16 M(+25.0%) | -$213.12 M(+4.4%) |
| Dec 2022 | -$204.21 M(+20.1%) | -$44.92 M(-24.9%) | -$204.21 M(-1.9%) |
| Sept 2022 | - | -$59.81 M(+14.5%) | -$208.27 M(+7.4%) |
| June 2022 | - | -$52.22 M(+10.5%) | -$193.93 M(+6.2%) |
| Mar 2022 | - | -$47.26 M(-3.5%) | -$182.63 M(+7.4%) |
| Dec 2021 | -$170.06 M(+93.2%) | -$48.98 M(+7.7%) | -$170.06 M(+13.4%) |
| Sept 2021 | - | -$45.47 M(+11.1%) | -$149.92 M(+18.1%) |
| June 2021 | - | -$40.91 M(+17.9%) | -$126.94 M(+20.0%) |
| Mar 2021 | - | -$34.69 M(+20.3%) | -$105.81 M(+20.2%) |
| Dec 2020 | -$88.05 M | -$28.84 M(+28.2%) | -$88.04 M(+16.7%) |
| Sept 2020 | - | -$22.49 M(+13.7%) | -$75.45 M(+8.2%) |
| June 2020 | - | -$19.79 M(+16.9%) | -$69.75 M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$16.93 M(+4.2%) | -$67.03 M(+137.6%) |
| Dec 2019 | -$28.21 M(-56.1%) | -$16.25 M(-3.3%) | -$28.21 M(-18.0%) |
| Sept 2019 | - | -$16.79 M(-1.6%) | -$34.39 M(-0.8%) |
| June 2019 | - | -$17.07 M(-177.9%) | -$34.67 M(+15.7%) |
| Mar 2019 | - | $21.90 M(-197.6%) | -$29.95 M(-53.4%) |
| Dec 2018 | -$64.26 M(+66.0%) | -$22.43 M(+31.4%) | -$64.26 M(+15.2%) |
| Sept 2018 | - | -$17.07 M(+38.2%) | -$55.79 M(+20.1%) |
| June 2018 | - | -$12.35 M(-0.4%) | -$46.46 M(+7.9%) |
| Mar 2018 | - | -$12.40 M(-11.2%) | -$43.05 M(+11.2%) |
| Dec 2017 | -$38.71 M(+182.5%) | -$13.97 M(+80.6%) | -$38.71 M(+64.8%) |
| Sept 2017 | - | -$7.73 M(-13.6%) | -$23.48 M(+8.8%) |
| June 2017 | - | -$8.95 M(+11.0%) | -$21.59 M(+31.6%) |
| Mar 2017 | - | -$8.06 M(-740.3%) | -$16.41 M(+19.7%) |
| Dec 2016 | -$13.70 M(-16.6%) | $1.26 M(-121.6%) | -$13.70 M(-8.4%) |
| Sept 2016 | - | -$5.84 M(+55.0%) | -$14.96 M(+64.0%) |
| June 2016 | - | -$3.77 M(-29.7%) | -$9.12 M(+70.3%) |
| Mar 2016 | - | -$5.36 M | -$5.36 M |
| Dec 2015 | -$16.43 M | - | - |
FAQ
- What is Mersana Therapeutics annual net profit?
- What is the all time high annual net income for Mersana Therapeutics?
- What is Mersana Therapeutics annual net income year-on-year change?
- What is Mersana Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly net income year-on-year change?
- What is Mersana Therapeutics TTM net profit?
- What is the all time high TTM net income for Mersana Therapeutics?
- What is Mersana Therapeutics TTM net income year-on-year change?
What is Mersana Therapeutics annual net profit?
The current annual net income of MRSN is -$171.67 M
What is the all time high annual net income for Mersana Therapeutics?
Mersana Therapeutics all-time high annual net profit is -$13.70 M
What is Mersana Therapeutics annual net income year-on-year change?
Over the past year, MRSN annual net profit has changed by +$32.54 M (+15.94%)
What is Mersana Therapeutics quarterly net profit?
The current quarterly net income of MRSN is -$11.50 M
What is the all time high quarterly net income for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly net profit is $21.90 M
What is Mersana Therapeutics quarterly net income year-on-year change?
Over the past year, MRSN quarterly net profit has changed by +$30.16 M (+72.39%)
What is Mersana Therapeutics TTM net profit?
The current TTM net income of MRSN is -$74.62 M
What is the all time high TTM net income for Mersana Therapeutics?
Mersana Therapeutics all-time high TTM net profit is -$5.36 M
What is Mersana Therapeutics TTM net income year-on-year change?
Over the past year, MRSN TTM net profit has changed by +$122.43 M (+62.13%)